Inventor
AHLSTRÖM CHRISTINE
SE3 patents
Patents
3 patentsUS11730735B2Aug 22, 2023
Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
ASTRAZENECA AB5 citations79
US12121517B2Oct 22, 2024
Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
ASTRAZENECA AB2 citations66
US12409174B2Sep 9, 2025
Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
ASTRAZENECA AB0 citations56